PRTN3 and post-transplant lymphoproliferative disease: While ACPA is highly specific for RA, it is also estimated to be present in about 3-5% of healthy individuals, though few studies have evaluated this in the setting of LD [15,16]. Previous smaller studies were unable to detect ACPA in patients with PTLD [9].